ロード中...
Association of fibrinogen and plasmin inhibitor, but not coagulation factor XIII gene polymorphisms with coronary artery disease
BACKGROUND: In the final phase of clot formation, fibrinogen constitutes frame, whereas factor XIII (FXIII) active form is responsible for the covalent cross-linking of fibrin fibres and plasmin inhibitor (PI), thus contributing to clot stability. It could be expected that any change of coagulation...
保存先:
| 出版年: | J Med Biochem |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Society of Medical Biochemists of Serbia, Belgrade
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7982289/ https://ncbi.nlm.nih.gov/pubmed/33776563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5937/jomb0-26839 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|